Endocrine Therapy Interruption, Resumption, and Outcomes Associated With Pregnancy After Breast Cancer
This cohort study examines interruption and resumption of endocrine therapy among women with breast cancer who became pregnant.
Authors
- Pragati Kenkare
- Lidia Schapira (ORCID: https://orcid.org/0000-0003-1431-6543)
- James Charles Dickerson (ORCID: https://orcid.org/0000-0002-8935-2939)
- Esther M. John (ORCID: https://orcid.org/0000-0003-3259-8003)
- Su‐Ying Liang (ORCID: https://orcid.org/0000-0002-6616-5970)
- Allison W. Kurian (ORCID: https://orcid.org/0000-0002-6175-9470)
- Rebecca M. Lewinsohn
- Julia D. Ransohoff (ORCID: https://orcid.org/0000-0003-3433-3076)
- Summer S. Han (ORCID: https://orcid.org/0000-0002-2013-6883)
- Rodolfo Martínez Chávez
- Victor Ritter (ORCID: https://orcid.org/0000-0002-1676-9573)
- Scarlett Lin Gomez (ORCID: https://orcid.org/0000-0002-5143-4867)
- Amanda Wheeler (ORCID: https://orcid.org/0000-0001-9755-674X)
- Ingrid Luo (ORCID: https://orcid.org/0009-0005-6649-962X)
- Mina Satoyoshi
Institutions
- Sutter Health (US)
- University of California, San Francisco (US)
- Stanford University (US)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2025-02-13
- DOI
- https://doi.org/10.1001/jamaoncol.2024.6868
- Citations
- 4
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 4.18